Graham Statement on Prescription Drug Pricing Hearing

WASHINGTON – Senate Judiciary Committee Chairman Lindsey Graham (R-South Carolina) made this statement following today’s hearing titled, "Intellectual Property and the Price of Prescription Drugs: Balancing Innovation and Competition." 

“We had a great hearing today on the complex issue of escalating prescription drug prices and patent abuse,” said Graham. “There seems to be a lot of common ground that would address the problem of companies gaming the system. I expect the committee to act in a bipartisan fashion this year to move the ball forward in terms of lowering prescription drug prices, while safeguarding innovation.”